In liver fibrosis, PPAR-γ is involved in hepatic stellate cell (HSC) activation and fibroblast transformation, which can reduce the overexpression of α-smooth muscle actin (α-SMA), type I collagen, and hydroxyproline in HSCs and thereby inhibit liver fibrosis [10–12]. This evidence concerns the gene ACTA1 and Hepatic fibrosis.